Irish investment firm Malin has invested $80m (€73m) in UK biotechnology firm Immunocore as part of Europe’s largest ever life sciences-focused funding round.

Malin, the life sciences- focused investment vehicle, run by former Elan executives, has announced a €34.5m investment in Altan Pharma, its second major investment in as many days.

Life sciences-focused investment firm Malin has invested $35m (€31m) for a minority stake in US-based drug development firm Melinta Therapeutics.